<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1335</article-id><article-id pub-id-type="doi">10.25208/vdv1335</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GUIDELINES FOR PRACTITIONERS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Assessment of the severity of atopic dermatitis — SCORAD and EASI</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка степени тяжести атопического дерматита — стандартизованные индексы тяжести SCORAD и EASI</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3805-8489</contrib-id><contrib-id contrib-id-type="spin">3604-6491</contrib-id><name-alternatives><name xml:lang="en"><surname>Karamova</surname><given-names>Arfenya E.</given-names></name><name xml:lang="ru"><surname>Карамова</surname><given-names>Арфеня  Эдуардовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>karamova@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9688-2727</contrib-id><contrib-id contrib-id-type="spin">3385-4723</contrib-id><name-alternatives><name xml:lang="en"><surname>Chikin</surname><given-names>Vadim V.</given-names></name><name xml:lang="ru"><surname>Чикин</surname><given-names>Вадим Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>chikin@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2553-0484</contrib-id><contrib-id contrib-id-type="spin">9552-7850</contrib-id><name-alternatives><name xml:lang="en"><surname>Znamenskaya</surname><given-names>Lyudmila F.</given-names></name><name xml:lang="ru"><surname>Знаменская</surname><given-names>Людмила Федоровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>znaml@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3129-0050</contrib-id><contrib-id contrib-id-type="spin">8334-2890</contrib-id><name-alternatives><name xml:lang="en"><surname>Aulova</surname><given-names>Kseniya M.</given-names></name><name xml:lang="ru"><surname>Аулова</surname><given-names>Ксения Максимовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>medical resident</p></bio><bio xml:lang="ru"><p>клинический ординатор</p></bio><email>aulovaksenia@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Dermatovenereology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Государственный научный центр дерматовенерологии и косметологии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-07-21" publication-format="electronic"><day>21</day><month>07</month><year>2022</year></pub-date><volume>98</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>53</fpage><lpage>60</lpage><history><date date-type="received" iso-8601-date="2022-05-26"><day>26</day><month>05</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-06-22"><day>22</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Karamova A.E., Chikin V.V., Znamenskaya L.F., Aulova K.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Карамова А.Э., Чикин В.В., Знаменская Л.Ф., Аулова К.М.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Karamova A.E., Chikin V.V., Znamenskaya L.F., Aulova K.M.</copyright-holder><copyright-holder xml:lang="ru">Карамова А.Э., Чикин В.В., Знаменская Л.Ф., Аулова К.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/1335">https://vestnikdv.ru/jour/article/view/1335</self-uri><abstract xml:lang="en"><p>Atopic dermatitis is one of the most prevalent chronic inflammatory skin diseases, which can vastly influence the patients’ quality of life. Objective assessment of severity is required to select adequate therapy and evaluate its effectiveness. Heterogeneous clinical manifestations with greatly varying severity make it difficult to assess the severity of atopic dermatitis. More than twenty methods are developed for the assessment of this disease’s severity. SCORAD, oSCORAD and EASI are the most elementary and reliable methods allowing to define the severity of atopic dermatitis relatively quickly and accurately. Each of these three methods has its own particularities, that could be advantages or disadvantages depending on circumstances.</p></abstract><trans-abstract xml:lang="ru"><p>Атопический дерматит является одним из наиболее распространенных хронических воспалительных заболеваний кожи, значимо нарушающих качество жизни пациентов. Для выбора адекватной терапии и оценки ее эффективности необходимо определение степени тяжести дерматоза. Гетерогенность и широкий диапазон тяжести возможных клинических проявлений, характерные для данного заболевания, делают затруднительной оценку степени тяжести атопического дерматита. В настоящее время разработано более 20 методов для оценки тяжести данного заболевания. Наиболее простыми и надежными методами, позволяющими относительно быстро и точно определить степень тяжести атопического дерматита, являются индексы SCORAD, oSCORAD и EASI. Каждый из трех методов оценки имеет свои особенности, дающие преимущество в определенных ситуациях и являющиеся недостатком в других.</p></trans-abstract><kwd-group xml:lang="en"><kwd>atopic dermatitis</kwd><kwd>severity</kwd><kwd>EASI</kwd><kwd>SCORAD</kwd><kwd>objective SCORAD</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>степень тяжести</kwd><kwd>EASI</kwd><kwd>SCORAD</kwd><kwd>объективный SCORAD</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Кубанов А.А., Намазова-Баранова Л.С., Хаитов Р.М., Ильина Н.И., Алексеева Е.А., Амбарчян Э.Т., и др. Атопический дерматит. Российский Аллергологический Журнал. 2021;18(3):44–92. [Kubanov AA, Namazova-Baranova LS, Haitov RM, Il'ina NI, Alekseeva EA, Ambarchjan JeT, et al. Atopicheskij dermatit. Rossijskij Allergologicheskij Zhurnal. 2021;18(3):44–92 (In Russ.)]. doi: 10.36691/RJA1474</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32(5): 657–682. doi: 10.1111/jdv.14891 Erratum in: J Eur Acad Dermatol Venereol. 2019; 33(7):1436.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–347. doi: 10.1016/j.anai.2018.07.006</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol. 2009;160(3):642–644. doi: 10.1111/j.1365-2133.2008.08941.x</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ahn C, Huang W. Clinical Presentation of Atopic Dermatitis. AdvExp Med Biol. 2017;1027:39–46. doi: 10.1007/978-3-319-64804-0_4</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Хаитов Р.М., Балаболкин И.И., Гущин И.С., Кубанова А.А., Астафьева Н.Г., Гребенюк В.Н., и др. Атопический дерматит: рекомендации для практических врачей. Под общей редакцией академика РАМН Р.М. Хаитова и члена-корреспондента РАМН, профессора А.А. Кубановой. Москва: «Фармарус Принт»; 2002. С. 5–6. [Haitov RM, Balabolkin II, Gushhin IS, Kubanova AA, Astaf'eva NG, Grebenjuk VN, et al. Atopicheskij dermatit: rekomendacii dlja prakticheskih vrachej. Pod obshhej redakciej akademika RAMN R.M. Haitova i chlena-korrespondenta RAMN, professora AA Kubanovoj. Moscow: “Farmarus Print”; 2002. Р. 5–6 (In Russ.)]</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Клинические рекомендации «Атопический дерматит». Год утверждения: 2021. Разработчик клинической рекомендации: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов»; Российская ассоциация аллергологов и клинических иммунологов; Союз педиатров России; Союз «Национальный альянс дерматовенерологов и косметологов». Одобрено Научно-практическим Советом Минздрава РФ. [Klinicheskie rekomendacii “Atopicheskij dermatit”. God utverzhdenija: 2021. Razrabotchik klinicheskoj rekomendacii: Obshherossijskaja obshhestvennaja organizacija "Rossijskoe obshhestvo dermatovenerologov i kosmetologov"; Rossijskaja associacija allergologov i klinicheskih immunologov; Sojuz pediatrov Rossii; Sojuz “Nacional'nyj al'jans dermatovenerologov i kosmetologov”. Odobreno Nauchno-prakticheskim Sovetom Minzdrava RF (In Russ.)]</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wittkowski A, Richards HL, Griffiths CE, Main CJ. Illness perception in individuals with atopic dermatitis. Psychol Health Med. 2007;12(4):433–444. doi: 10.1080/13548500601073928</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Стародубов В.И., Александрова Г.А., Богданова Е.В., Голубев Н.А., Мелехина Л.Е., Огрызко Е.В., и др. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. Заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2019–2020 гг. Статистические материалы. М.: Департамент мониторинга, анализа и стратегического развития здравоохранения Минздрава России, ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России, ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России, 2021. Доступно по: Медицинская статистика (mednet.ru). [Starodubov VI, Alexandrova GA, Bogdanova EV, Golubev NA, Melekhina LE, Ogryzko EV, et al. Resources and performance of dermatovenerologicalmedicalorganizations. The incidence of sexually transmitted infections, infectious skin diseases and skin diseases in 2019–2020. Statistical materials. Moscow: Department of Monitoring, Analysis and Strategic Development of Healthcare of the Ministry of Health of Russia, Federal State Budgetary Institution "Central Research Institute for Organization and Informatization of Healthcare" of the Ministry of Health of Russia, Federal State Budgetary Institution "State Scientific Center for Dermatovenereology and Cosmetology" of the Ministry of Health of Russia, 2021. Available at: Medicinskaja statistika (mednet.ru) (In Russ.)]</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, et al. HOME initiative collaborators. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134(4):800–807. doi: 10.1016/j.jaci.2014.07.043</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol. 2003;120(6):932–941. doi: 10.1046/j.1523-1747.2003.12251.x</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Schmitt J, Langan S, Williams HC. European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120(6):1389–1398. doi: 10.1016/j.jaci.2007.08.011</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Rehal B, Armstrong AW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS One. 2011;13;6(4):17520. doi: 10.1371/journal.pone.0017520 Erratum in: PLoS One. 2011;6(6):10.1371/annotation/6d5e99c5-bd8f-4cef-b77a-fbb795633da0. Armstrong, April [Corrected to Armstrong, April W]</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Oranje AP. Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score. Curr Probl Dermatol. 2011;41:149–155. doi: 10.1159/000323308</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Oranje AP, Stalder JF, Taïeb A, Tasset C, de Longueville M. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol. 1997;8(1):28–34. doi: 10.1111/j.1399-3038.1997.tb00139.x</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: the SCORAD index — consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23–31.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020;34(12):2717–2744. doi: 10.1111/jdv.16892</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10–19. doi: 10.1159/000245677</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, et al. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. Br J Dermatol. 2020. doi: 10.1111/bjd.19673</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Oakley A. EASI score. https://dermnetnz.org/topics/easi-score (2015)</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Leshem YA, Hajar T, Hanifin JM, Simpson EL. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015;172(5):1353–1357. doi: 10.1111/bjd.13662</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177(5):1316–1321. doi: 10.1111/bjd.15641</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, et al. European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30(5):729–747. doi: 10.1111/jdv.13599</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, et al. Relationship between EASI and SCORAD severity assessments for atopic dermatitis. J Allergy Clin Immunol. 2017;140(6):1708-1710.e1. doi: 10.1016/j.jaci.2017.04.052</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, et al. Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337–1347. doi: 10.1016/j.jaci.2013.07.008</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Chopra R, Silverberg JI. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatol. 2018;36(5):606–615. doi: 10.1016/j.clindermatol.2018.05.012</mixed-citation></ref></ref-list></back></article>
